• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸二酯酶 10A 抑制基于中风类型导致脑区特异性恢复。

Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type.

机构信息

Departments of Neurology and of Neurobiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Departments of Psychology and of Computer Science, University of Southern California, Los Angeles, CA, USA.

出版信息

Transl Stroke Res. 2021 Apr;12(2):303-315. doi: 10.1007/s12975-020-00819-8. Epub 2020 May 6.

DOI:10.1007/s12975-020-00819-8
PMID:32378029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7644574/
Abstract

Stroke is the leading cause of adult disability. Recovery of function after stroke involves signaling events that are mediated by cAMP and cGMP pathways, such as axonal sprouting, neurogenesis, and synaptic plasticity. cAMP and cGMP are degraded by phosphodiesterases (PDEs), which are differentially expressed in brain regions. PDE10A is highly expressed in the basal ganglia/striatum. We tested a novel PDE10A inhibitor (TAK-063) for its effects on functional recovery. Stroke was produced in mice in the cortex or the striatum. Behavioral recovery was measured to 9 weeks. Tissue outcome measures included analysis of growth factor levels, angiogenesis, neurogenesis, gliogenesis, and inflammation. TAK-063 improved motor recovery after striatal stroke in a dose-related manner, but not in cortical stroke. Recovery of motor function correlated with increases in striatal brain-derived neurotrophic factor. TAK-063 treatment also increased motor system axonal connections. Stroke affects distinct brain regions, with each comprising different cellular and molecular elements. Inhibition of PDE10A improved recovery of function after striatal but not cortical stroke, consistent with its brain localization. This experiment is the first demonstration of brain region-specific enhanced functional recovery after stroke, and indicates that differential molecular signaling between brain regions can be exploited to improve recovery based on stroke subtype.

摘要

中风是导致成年人残疾的主要原因。中风后的功能恢复涉及由 cAMP 和 cGMP 途径介导的信号事件,如轴突发芽、神经发生和突触可塑性。cAMP 和 cGMP 被磷酸二酯酶 (PDEs) 降解,PDEs 在脑区中差异表达。PDE10A 在基底节/纹状体中高度表达。我们测试了一种新型的 PDE10A 抑制剂 (TAK-063) 对功能恢复的影响。在皮层或纹状体中诱导小鼠中风。在 9 周内测量行为恢复情况。组织结果测量包括生长因子水平、血管生成、神经发生、神经胶质发生和炎症的分析。TAK-063 以剂量相关的方式改善纹状体中风后的运动恢复,但对皮层中风没有影响。运动功能的恢复与纹状体脑源性神经营养因子的增加相关。TAK-063 治疗还增加了运动系统轴突的连接。中风影响不同的脑区,每个脑区包含不同的细胞和分子成分。PDE10A 的抑制作用改善了纹状体中风后的功能恢复,但不改善皮层中风后的功能恢复,这与其在大脑中的定位一致。该实验首次证明了中风后大脑区域特异性功能恢复增强,表明基于中风亚型,可以利用脑区之间的差异分子信号来改善恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/4f6ec644ac72/12975_2020_819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/ef7bba3e4672/12975_2020_819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/9f1abcf9fbc3/12975_2020_819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/7bbcf8b11687/12975_2020_819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/cc8e88999554/12975_2020_819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/a9f14e28920d/12975_2020_819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/4f6ec644ac72/12975_2020_819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/ef7bba3e4672/12975_2020_819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/9f1abcf9fbc3/12975_2020_819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/7bbcf8b11687/12975_2020_819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/cc8e88999554/12975_2020_819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/a9f14e28920d/12975_2020_819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/7925477/4f6ec644ac72/12975_2020_819_Fig6_HTML.jpg

相似文献

1
Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type.磷酸二酯酶 10A 抑制基于中风类型导致脑区特异性恢复。
Transl Stroke Res. 2021 Apr;12(2):303-315. doi: 10.1007/s12975-020-00819-8. Epub 2020 May 6.
2
Phosphodiesterase 10A deactivation induces long-term neurological recovery, Peri-infarct remodeling and pyramidal tract plasticity after transient focal cerebral ischemia in mice.磷酸二酯酶10A失活可诱导小鼠短暂性局灶性脑缺血后长期神经功能恢复、梗死灶周围重塑和锥体束可塑性。
Exp Neurol. 2022 Dec;358:114221. doi: 10.1016/j.expneurol.2022.114221. Epub 2022 Sep 6.
3
Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of Dystonia.肌张力障碍转基因小鼠模型纹状体苍白球和纹状体终纹床核通路中磷酸二酯酶-10A的反向变化
J Neurosci. 2017 Feb 22;37(8):2112-2124. doi: 10.1523/JNEUROSCI.3207-15.2016. Epub 2017 Jan 23.
4
TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington's Disease.新型磷酸二酯酶10A抑制剂TAK-063可保护R6/2亨廷顿舞蹈病小鼠模型的纹状体神经细胞免于退化,并改善其行为缺陷。
J Pharmacol Exp Ther. 2017 Jan;360(1):75-83. doi: 10.1124/jpet.116.237388. Epub 2016 Nov 3.
5
Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.在运动症状出现之前,亨廷顿舞蹈病转基因小鼠纹状体中的磷酸二酯酶mRNA和蛋白质水平降低。
Neuroscience. 2004;123(4):967-81. doi: 10.1016/j.neuroscience.2003.11.009.
6
Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.磷酸二酯酶10A与纹状体中的突触信号复合物相连。
J Biol Chem. 2015 May 8;290(19):11936-47. doi: 10.1074/jbc.M114.595769. Epub 2015 Mar 11.
7
Characterization of binding and inhibitory properties of TAK-063, a novel phosphodiesterase 10A inhibitor.新型磷酸二酯酶10A抑制剂TAK-063的结合特性与抑制特性表征
PLoS One. 2015 Mar 27;10(3):e0122197. doi: 10.1371/journal.pone.0122197. eCollection 2015.
8
Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.抑制纹状体特异性磷酸二酯酶 PDE10A 可改善亨廷顿病 R6/2 小鼠模型纹状体和皮质的病理学变化。
PLoS One. 2010 Oct 15;5(10):e13417. doi: 10.1371/journal.pone.0013417.
9
PDE2A Inhibition Enhances Axonal Sprouting, Functional Connectivity, and Recovery after Stroke.PDE2A 抑制增强卒中后轴突发芽、功能连接和恢复。
J Neurosci. 2022 Nov 2;42(44):8225-8236. doi: 10.1523/JNEUROSCI.0730-22.2022. Epub 2022 Sep 26.
10
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.抑制纹状体富集磷酸二酯酶PDE10A:一种治疗精神病的新方法。
Neuropharmacology. 2006 Aug;51(2):386-96. doi: 10.1016/j.neuropharm.2006.04.013. Epub 2006 Jun 15.

引用本文的文献

1
Novel potential neuroprotective targets for DengZhanXiXin injection in middle cerebral artery occlusion rats recommended by quantitative proteomics and simulated docking.定量蛋白质组学和模拟对接推荐的灯盏细辛注射液对大脑中动脉闭塞大鼠的新型潜在神经保护靶点
Front Neurosci. 2025 Jul 7;19:1499214. doi: 10.3389/fnins.2025.1499214. eCollection 2025.
2
Temporal and Spatial Gene Expression Profile of Stroke Recovery Genes in Mice.脑卒中后恢复相关基因在小鼠中的时空表达谱。
Genes (Basel). 2023 Feb 9;14(2):454. doi: 10.3390/genes14020454.
3
A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects.

本文引用的文献

1
CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury.CCR5 是中风和创伤性脑损伤后恢复的治疗靶点。
Cell. 2019 Feb 21;176(5):1143-1157.e13. doi: 10.1016/j.cell.2019.01.044.
2
CREB controls cortical circuit plasticity and functional recovery after stroke.CREB 控制皮质回路可塑性和中风后的功能恢复。
Nat Commun. 2018 Jun 8;9(1):2250. doi: 10.1038/s41467-018-04445-9.
3
Nogo receptor blockade overcomes remyelination failure after white matter stroke and stimulates functional recovery in aged mice.
一种磷酸二酯酶10A(PDE10A)抑制剂CPL500036是一种新型药物,可调节纹状体功能,且无大多数抗精神病药物的副作用。
Front Pharmacol. 2022 Nov 9;13:999685. doi: 10.3389/fphar.2022.999685. eCollection 2022.
4
PDE2A Inhibition Enhances Axonal Sprouting, Functional Connectivity, and Recovery after Stroke.PDE2A 抑制增强卒中后轴突发芽、功能连接和恢复。
J Neurosci. 2022 Nov 2;42(44):8225-8236. doi: 10.1523/JNEUROSCI.0730-22.2022. Epub 2022 Sep 26.
5
Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke.磷酸二酯酶10A是缺血性中风小鼠模型中神经保护的关键靶点。
Mol Neurobiol. 2022 Jan;59(1):574-589. doi: 10.1007/s12035-021-02621-5. Epub 2021 Nov 4.
6
Delayed atomoxetine or fluoxetine treatment coupled with limited voluntary running promotes motor recovery in mice after ischemic stroke.延迟使用托莫西汀或氟西汀治疗并结合有限的自主跑步可促进缺血性中风后小鼠的运动恢复。
Neural Regen Res. 2021 Jul;16(7):1244-1251. doi: 10.4103/1673-5374.301031.
7
Encouraging an excitable brain state: mechanisms of brain repair in stroke.鼓励兴奋的大脑状态:中风后的大脑修复机制。
Nat Rev Neurosci. 2021 Jan;22(1):38-53. doi: 10.1038/s41583-020-00396-7. Epub 2020 Nov 12.
Nogo受体阻断可克服白质中风后髓鞘再生失败并促进老年小鼠的功能恢复。
Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):E8453-E8462. doi: 10.1073/pnas.1615322113. Epub 2016 Dec 12.
4
TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington's Disease.新型磷酸二酯酶10A抑制剂TAK-063可保护R6/2亨廷顿舞蹈病小鼠模型的纹状体神经细胞免于退化,并改善其行为缺陷。
J Pharmacol Exp Ther. 2017 Jan;360(1):75-83. doi: 10.1124/jpet.116.237388. Epub 2016 Nov 3.
5
The mouse cortico-striatal projectome.小鼠皮质-纹状体投射图谱。
Nat Neurosci. 2016 Aug;19(8):1100-14. doi: 10.1038/nn.4332. Epub 2016 Jun 20.
6
Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke.水凝胶递送的脑源性神经营养因子促进中风后的组织修复和恢复。
J Cereb Blood Flow Metab. 2017 Mar;37(3):1030-1045. doi: 10.1177/0271678X16649964. Epub 2016 Jul 20.
7
Reversal of the Detrimental Effects of Post-Stroke Social Isolation by Pair-Housing is Mediated by Activation of BDNF-MAPK/ERK in Aged Mice.配对饲养逆转中风后社会隔离对老年小鼠的有害影响是由BDNF-MAPK/ERK的激活介导的。
Sci Rep. 2016 Apr 29;6:25176. doi: 10.1038/srep25176.
8
Rolipram stimulates angiogenesis and attenuates neuronal apoptosis through the cAMP/cAMP-responsive element binding protein pathway following ischemic stroke in rats.咯利普兰通过环磷酸腺苷/环磷酸腺苷反应元件结合蛋白途径刺激大鼠缺血性中风后的血管生成并减轻神经元凋亡。
Exp Ther Med. 2016 Mar;11(3):1005-1010. doi: 10.3892/etm.2015.2958. Epub 2015 Dec 29.
9
TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.TAK-063是一种PDE10A抑制剂,能平衡直接和间接通路的激活,在多种实验范式中展现出强效的类抗精神病作用。
Neuropsychopharmacology. 2016 Aug;41(9):2252-62. doi: 10.1038/npp.2016.20. Epub 2016 Feb 5.
10
The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models.磷酸二酯酶10A选择性抑制剂TAK-063改善啮齿动物模型中与精神分裂症相关的认知功能。
J Pharmacol Exp Ther. 2016 Mar;356(3):587-95. doi: 10.1124/jpet.115.230482. Epub 2015 Dec 16.